Frontier Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Frontier Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-28,067	Closed	-$2.31M	–	352
2015 Q3	$2.31M	Sell	28,067 -51,983	-65%	-$6.64M	0.02%	298
2015 Q2	$13M	Buy	80,050 +51,577	+181%	+$17.4M	0.09%	248
2015 Q1	$11.5M	Sell	28,473 -23,425	-45%	-$9.9M	0.08%	261
2014 Q4	$28M	Buy	51,898 +12,303	+31%	+$4.74M	0.21%	167
2014 Q3	$13.5M	Buy	+39,595	New	+$11.8M	0.11%	228

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Frontier Capital Management's ADVM Position: Q4 2015 in Review

Frontier Capital Management sold out of Adverum Biotechnologies (ADVM) in Q4 2015, closing a stake of 28,067 shares — an estimated $2.31M sold.

Frontier Capital Management first reported a position in ADVM in Q3 2014 and held it in 5 quarters. The position peaked at $28M in Q4 2014. 76 funds tracked by Wall St. Rank hold ADVM as of Q4 2015.

Frontier Capital Management reported no remaining Adverum Biotechnologies position as of Q4 2015 after selling out during the quarter.
Frontier Capital Management sold 28,067 Adverum Biotechnologies shares in Q4 2015, an estimated $2.31M.
Frontier Capital Management first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 5 quarters.
Frontier Capital Management's Adverum Biotechnologies position peaked at $28M in Q4 2014.
76 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2015.

Based on Frontier Capital Management's 13F filing for Q4 2015, filed 27 Jan 2016.